评论 13
过滤器:
评分
语言
种类:
最近的
J
9 几个月前

I have been using Cellectis for my genetic enginee...

I have been using Cellectis for my genetic engineering projects for quite some time now and I have always been satisfied with their services. The team is knowledgeable and responsive, and the results have always been accurate. I highly recommend Cellectis for all genetic engineering needs.

T
10 几个月前

I have used Cellectis for my genetic engineering p...

I have used Cellectis for my genetic engineering projects and I couldn't be happier with the results. The quality of their work is top-notch and the team is extremely professional. I highly recommend this company for all genetic engineering needs. 👍

R
11 几个月前

🔥 Cellectis is my go-to company for all my genetic...

🔥 Cellectis is my go-to company for all my genetic engineering needs. Their services are outstanding and their team is highly skilled. They always deliver exceptional results in a timely manner. I cannot recommend them enough!

D
12 几个月前

I've had a great experience working with Cellectis...

I've had a great experience working with Cellectis. Their genetic engineering services are outstanding and their team is highly skilled. The entire process, from consultation to project completion, was smooth and hassle-free. I would definitely choose Cellectis again. 👌

C
1年以前

I have been a customer of Cellectis for over a yea...

I have been a customer of Cellectis for over a year now and I must say, their services are excellent. The staff is very knowledgeable and always ready to help. The website is user-friendly and easy to navigate. I would highly recommend Cellectis to anyone looking for genetic engineering services.

D
1年以前

I recently availed Cellectis' genetic engineering ...

I recently availed Cellectis' genetic engineering services and I must say, I'm impressed! They have a wide range of solutions that fit different needs. The team is friendly and always available for assistance. 👏 Highly recommended!

G
1年以前

The genetic engineering services provided by this ...

The genetic engineering services provided by this company are excellent. I have used their services multiple times and they have never disappointed. The analysis reports are detailed and the turnaround time is impressive. Highly recommended!

K
1年以前

I'm really happy with the genetic engineering serv...

I'm really happy with the genetic engineering services provided by Cellectis. Their team is efficient, knowledgeable, and always ready to assist. The website is easy to navigate and the overall experience has been great. I would definitely choose Cellectis again for my future projects!

G
1年以前

The services provided by Cellectis have been excel...

The services provided by Cellectis have been excellent. The team is knowledgeable, responsive, and delivers results on time. I'm really satisfied with their genetic engineering solutions. Highly recommend!

S
1年以前

👍 Cellectis is a fantastic company to work with! T...

👍 Cellectis is a fantastic company to work with! Their services are top-notch and their team is extremely professional. They have a wide range of genetic engineering solutions that cater to various requirements. I'm really impressed with their work and would highly recommend them!

G
1年以前

I recently used a company to get my genome sequenc...

I recently used a company to get my genome sequenced and I was very impressed with the results. The analysis provided by the company was detailed and accurate. The website was easy to use and the whole process was smooth. I would definitely recommend this company to others.

关于Cellectis

Cellectis:使用下一代 CAR T 细胞彻底改变癌症治疗

Cellectis 是一家临床阶段的生物制药公司,致力于利用基因编辑和细胞治疗的最新进展开发创新的癌症治疗方法。该公司的使命是通过创造下一代 CAR T 细胞来治愈癌症,这些细胞可以有效地靶向和破坏癌细胞,同时不伤害健康细胞。

Cellectis 成立于 1999 年,二十多年来一直处于基因编辑技术的前沿。该公司的专长在于其专有的 TALEN® 基因编辑平台,该平台允许对活细胞内的基因进行精确修改。这项技术使 Cellectis 能够开发出一系列有可能彻底改变癌症治疗的创新疗法。

Cellectis 最有前途的疗法之一是其下一代 CAR T 细胞,其设计比传统 CAR T 细胞疗法更有效、更安全。这些新的 CAR T 细胞是使用 Cellectis 专有的基因编辑技术设计的,该技术可以对免疫系统的 T 细胞进行精确修饰,从而更好地识别和攻击癌细胞。

这些下一代 CAR T 细胞的潜在好处是巨大的。传统的 CAR-T 细胞疗法在治疗某些类型的血癌方面取得了显著成功,但由于无法有效穿透实体瘤,因此在治疗实体瘤方面存在局限性。然而,使用 Cellectis 的新方法,可以克服这些限制,因为它们也旨在靶向实体瘤。

此外,由于这些新的 CAR-T 细胞是使用患者自身的免疫系统细胞而非供体细胞(如其他公司所使用的)进行工程改造的,因此人体免疫系统产生排斥反应或其他不良反应的风险较小。

Cellectis 已经在将其下一代 CAR-T 细胞疗法投入临床使用方面取得了重大进展。仅在 2020 年,该公司就宣布了多项 I 期试验的积极结果,这些试验评估了该疗法对急性髓性白血病 (AML) 和 B 细胞急性淋巴细胞白血病 (B-ALL) 等多种癌症的治疗效果。这些结果显示出有前途的疗效和可控的安全性。

此外,Cellectis 还与领先的制药公司建立了合作伙伴关系,例如辉瑞公司、Servier Laboratories SAS 和 Allogene Therapeutics Inc.,一旦获得全球监管机构的批准,这些公司将帮助进一步加快开发工作,同时提供商业化所需的额外资源。

总之,Cellectis 为寻求投资尖端生物技术公司的投资者提供了一个令人兴奋的机会,这些公司专注于开发针对人类最致命疾病之一——癌症的新疗法!凭借其专有的基因编辑平台和创新方法开发下一代细胞免疫疗法,如下一代 CAR-T 细胞;它可能会永远改变我们治疗这种疾病的方式!

已翻译